Big U.S. pharmacies square off on Daraprim supplies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Leerink Partners Remains Bullish Following Express Scripts (ESRX) 2016 Guidance Release
December 22, 2015 9:19 AM ESTLeerink Partners reiterated an Outperform rating on Express Scripts (NASDAQ: ESRX) after the company issued its 2016 guidance this morning. The guidance calls for adjusted EPS of $6.08 to $6.28 (vs. consensus of $6.05). Total 2016 adjusted claims guidance of 1,255M-1,295M is inline with the preliminary claims... More
